Alkem Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹3622.1
- Today's High:
- ₹3674.7
- Open Price:
- ₹3655
- 52W Low:
- ₹2828.3415
- 52W High:
- ₹4270.9502
- Prev. Close:
- ₹3630
- Volume:
- 224077
Company Statistics
- Market Cap.:
- ₹435.55 billion
- Book Value:
- 756.517
- Revenue TTM:
- ₹119.91 billion
- Operating Margin TTM:
- 12.59%
- Gross Profit TTM:
- ₹65.79 billion
- Profit Margin:
- 9.54%
- Return on Assets TTM:
- 5.93%
- Return on Equity TTM:
- 11.01%
Company Profile
Alkem Laboratories Limited had its IPO on under the ticker symbol ALKEM.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Alkem Laboratories Limited has a staff strength of 16,871 employees.
Stock update
Shares of Alkem Laboratories Limited opened at ₹3655 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹3622.1 - ₹3674.7, and closed at ₹3635.35.
This is a +0.15% increase from the previous day's closing price.
A total volume of 224,077 shares were traded at the close of the day’s session.
In the last one week, shares of Alkem Laboratories Limited have slipped by -0.42%.
Alkem Laboratories Limited's Key Ratios
Alkem Laboratories Limited has a market cap of ₹435.55 billion, indicating a price to book ratio of 4.105 and a price to sales ratio of 3.5279.
In the last 12-months Alkem Laboratories Limited’s revenue was ₹119.91 billion with a gross profit of ₹65.79 billion and an EBITDA of ₹17.79 billion. The EBITDA ratio measures Alkem Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Alkem Laboratories Limited’s operating margin was 12.59% while its return on assets stood at 5.93% with a return of equity of 11.01%.
In Q2, Alkem Laboratories Limited’s quarterly earnings growth was a positive 124.5% while revenue growth was a positive 15.2%.
Alkem Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 38.1725
- PEG
Its diluted EPS in the last 12-months stands at ₹95.43 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alkem Laboratories Limited’s profitability.
Alkem Laboratories Limited stock is trading at a EV to sales ratio of 3.4305 and a EV to EBITDA ratio of 22.2155. Its price to sales ratio in the trailing 12-months stood at 3.5279.
Alkem Laboratories Limited stock pays annual dividends of ₹25 per share, indicating a yield of 0.55% and a payout ratio of 26.15%.
Balance sheet and cash flow metrics
- Total Assets
- ₹137.57 billion
- Total Liabilities
- ₹37.07 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 26.15%
Alkem Laboratories Limited ended 2024 with ₹137.57 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹137.57 billion while shareholder equity stood at ₹90.45 billion.
Alkem Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹37.07 billion in other current liabilities, 239100000.00 in common stock, ₹90.21 billion in retained earnings and ₹4.13 billion in goodwill. Its cash balance stood at ₹2.74 billion and cash and short-term investments were ₹31.24 billion. The company’s total short-term debt was ₹13,071,500,000 while long-term debt stood at ₹0.00.
Alkem Laboratories Limited’s total current assets stands at ₹87.30 billion while long-term investments were ₹0 and short-term investments were ₹5.07 billion. Its net receivables were ₹21.32 billion compared to accounts payable of ₹11.65 billion and inventory worth ₹26.08 billion.
In 2024, Alkem Laboratories Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Alkem Laboratories Limited paid ₹0.26 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹3635.35
- 52-Week High
- ₹4270.9502
- 52-Week Low
- ₹2828.3415
- Analyst Target Price
- ₹
Alkem Laboratories Limited stock is currently trading at ₹3635.35 per share. It touched a 52-week high of ₹4270.9502 and a 52-week low of ₹4270.9502. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹3753.53 and 200-day moving average was ₹3350.08 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7391.7% of the company’s stock are held by insiders while 1931.9% are held by institutions.
Frequently Asked Questions About Alkem Laboratories Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India.